BRIEF published on 09/20/2024 at 08:35, 1 year 9 months ago The Grounds Real Estate Development AG: Shareholders Approve Capital Increase Shareholders Capital Increase Subscription Rights Bond Conversion H.I.G. Capital
BRIEF published on 09/20/2024 at 08:35, 1 year 9 months ago The Grounds Real Estate Development AG : les actionnaires approuvent l'augmentation de capital Actionnaires Augmentation De Capital Droits De Souscription Conversion D'obligations HIG Capital
BRIEF published on 09/20/2024 at 08:05, 1 year 9 months ago Résultats encourageants de l'essai NanoLithium sur la maladie d'Alzheimer Biotechnologie Alzheimer Nanolithium Essai Clinique Tolérance
BRIEF published on 09/20/2024 at 08:05, 1 year 9 months ago Encouraging results from NanoLithium trial on Alzheimer's disease Biotechnology Alzheimer Nanolithium Clinical Trial Tolérance
BRIEF published on 09/20/2024 at 08:05, 1 year 9 months ago AgroGeneration Reports Significant Impact on 2024 Harvest Due to Severe Drought and Ongoing Conflict Financial Outlook AgroGeneration Ukraine Drought 2024 Harvest Crop Yields
BRIEF published on 09/20/2024 at 08:05, 1 year 9 months ago AgroGeneration signale un impact significatif sur la récolte de 2024 en raison d'une grave sécheresse et d'un conflit en cours Perspectives Financières AgroGeneration Récolte 2024 Sécheresse En Ukraine Rendements Des Cultures
BRIEF published on 09/20/2024 at 07:35, 1 year 9 months ago XTPL Reports PLN 5.6 Million in H1 2024 Sales and Advances Industrial Projects XTPL Delta Printing System H1 2024 Industrial Projects 2023-2026 Strategy
BRIEF published on 09/20/2024 at 07:35, 1 year 9 months ago XTPL annonce un chiffre d'affaires de 5,6 millions PLN au premier semestre 2024 et fait progresser ses projets industriels XTPL Système D'impression Delta Premier Semestre 2024 Projets Industriels Stratégie 2023-2026
BRIEF published on 09/20/2024 at 07:35, 1 year 9 months ago Sensorion dévoile de nouvelles avancées cliniques prometteuses Biotechnologie Essais Cliniques Thérapie Génique Perte Auditive Petite Molécule
BRIEF published on 09/20/2024 at 07:35, 1 year 9 months ago Sensorion Unveils Promising New Clinical Advances Biotechnology Clinical Trials Gene Therapy Hearing Loss Small Molecule
Published on 06/27/2026 at 01:40, 7 hours 9 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 49 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 49 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 9 hours 59 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 34 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 44 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 45 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 13 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 9 hours 13 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 22 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
